FDA Inspection
Dunson LPDunson LP – FDA Inspection, Feb 25, 2011
Record Details
This FDA Inspection record concerns Dunson LP, with an inspection on February 25, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Dunson LP
- Inspection Date
- February 25, 2011
- Product Type
- Biologics
View Company Profile
ID · 5d96f9a3-a9ef-49cb-8e6c-a718d7ab5876
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 716185
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.290(e)Documenting disposition of each HCT/P
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Dunson LP
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 7, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Dunson LP
- FDA Inspection 818099 - 2013-02-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.